PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL

Lobbying Spend

—

Filings

Firms Hired

Active Period

2025–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
W STRATEGIES, LLC	—	6

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	5
SENATE	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	6

PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL — Lobbying Disclosure | Poliscope